API Product   :    Itraconazole
CEP   :    ¤
WCC   :    ?
Therapeutic Use    :    Ophthalmologicals; Gynecological anti-Infectives; Antifungals, dermatological; All Other Therapeutic Products; Ophthalmological/Otological Combinations
Ophthalmologicals; Gynecological anti-Infectives; Antifungals, dermatological; All Other Therapeutic Products; Ophthalmological/Otological Combinations
Originator   :    HedgePath Pharmaceuticals
CAS No.    :    84625-61-6
Trade Name.   :    SPORANOX
Molecular Weight   :    705.64 g/ mol
705.64 g/ mol
Molecular Formula   :    C35H38Cl2N8O4
Itraconazole tablets and capsules are used to treat fungal infections of the toenails. Itraconazole oral solution (liquid) is used to treat yeast infections of the mouth and throat or of the esophagus (tube that connects the throat to the stomach). Itraconazole is in a class of antifungals called triazoles.
Itraconazole is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. It may be given by mouth or intravenously. Common side effects include nausea, diarrhea, abdominal pain, rash, and headache. Severe side effects may include liver problems, heart failure, Stevens-Johnson syndrome and allergic reactions including anaphylaxis. It is unclear if use during pregnancy or breastfeeding is safe. It is in the triazole family of medications. It stops fungal growth by affecting the cell membrane or affecting their metabolism.